Research Tools and Reagents
Category VIEW ALL
Microbial Organelle Positioning Systems and Uses
Technology No. 2023-457
Stem Cell-based Therapy for Male Infertility
Technology No. 2021-502
Missed Nursing Care (MISSCARE) Survey
Technology No. 2025-501
Generation of Human Sertoli Cells to Support In Vivo and In Vitro Gametogenesis
Technology No. 2021-502
Immune Isolating Device With Improved Diffusion
Technology No. 2024-096
Caspase-9 driven murine model of selective cell apoptosis and efferocytosis
Technology No. 2023-247
Human I1061T NPC1 mice
Technology No. 2022-414
B6;129-Elovl4/J
Technology No. 2022-244
Calcr-cre Mice
Technology No. 2022-225
Cckbr-cre Mice
Technology No. 2022-209
Myers Lab Prlh Mouse Lines
Technology No. 2022-208
Col2a1-tTA Transgenic Mice
Technology No. 2022-034
Conditional Cre Activity Specifically in Eythroid Cells
Technology No. 2022-009
Mice Genetically Engineered to Lack the Alpha and Delta Isoforms of SH2B1
Technology No. 2021-493
Mouse Strain for Targeted Oncogenesis
Technology No. 2021-448
BAF60c Flox Mouse Strain
Technology No. 2021-398
Cxcl12-iCreERT2 Bacterial Artificial Chromosome Transgenic Mice
Technology No. 2021-377
BAF60a Flox Mouse Strain
Technology No. 2021-371
hProCpepSFGFP Transgenic Mouse
Technology No. 2021-061
ATP13a2 KO Mouse Model
Technology No. 2020-498
A Genetically and Histologically Accurate Mouse Model of Basal Cell Carcinoma
Technology No. 2020-294
Nrlp-GFP Mice
Technology No. 2019-135
Mice Carrying Deletions of Individual X Chromosomal Palindrome Arms
Technology No. 2019-025
Complementing Cell Line for Growing Adenovirus IVa2 Mutants
Technology No. 2018-492
Stable Expression of IDH1 Mutants in Human Astrocyte Cells
Technology No. 2018-489
Mice Deficient in Phosphorylation of Eukaryotic Translation Initiation Factor 2 Alpha (eIF2a)
Technology No. 2018-483
Stable A549 Cell Lines Generated by Crispr-Cas9 Genome Editing
Technology No. 2018-446
Mouse Models for Hematological Research and Plasminogen Activation (Mcfd2 knockout mice)
Technology No. 2015-527
Mouse Models for Hematological Research and Plasminogen Activation (Lman1 targeted mutation)
Technology No. 2015-526
Mouse Models for Hematological Research and Plasminogen Activation (humanized PLG)
Technology No. 2015-518
Mouse Models for Hematological Research and Plasminogen Activation (ADAMTS13-deficient)
Technology No. 2015-517
Mouse Models for Hematological Research and Plasminogen Activation (F5 Leiden mutation)
Technology No. 2015-516
Mouse Models for Immunology, Inflammation, and Autoimmunity Research (FIZZ1 KO)
Technology No. 2015-510
Mouse Models for Immunology, Inflammation, and Autoimmunity Research (18 COX-2)
Technology No. 2015-509
Mouse Models for Immunology, Inflammation, and Autoimmunity Research (Fut7/Fut4 knock-out)
Technology No. 2015-508
Mouse Models for Internal/Organ and Bone Research (Fut2tm1Sdo knock-out)
Technology No. 2015-507
Mouse Models for Internal/Organ and Bone Research (Pthrp-creER)
Technology No. 2015-505
Mouse Models for Internal/Organ and Bone Research (PthrpmCherry)
Technology No. 2015-504
Mouse Models for Internal/Organ and Bone Research (GasKO)
Technology No. 2015-503
Mouse Models for Internal/Organ and Bone Research (CDX2P-CreERT2)
Technology No. 2015-501
Mouse Models for Internal/Organ and Bone Research (CDX2P9.5-G22Cre)
Technology No. 2015-500
Mouse Models for Internal/Organ and Bone Research (CDX2-cre)
Technology No. 2015-499
Mouse Models for Internal/Organ and Bone Research (12.4KVil-EGFP)
Technology No. 2015-498
Mouse Models for Developmental Biology Research (FUT1-deficient mice)
Technology No. 2015-496
Mouse Models for Developmental Biology Research (TERTfl)
Technology No. 2015-495
Mouse Models for Developmental Biology Research (Ash1l gene trapped)
Technology No. 2015-494
Mouse Models for Developmental Biology Research (Pitx2flox)
Technology No. 2015-493
Mouse Models for Developmental Biology Research (Lhb-cre)
Technology No. 2015-492
Mouse Models for Developmental Biology Research (GH1-cre)
Technology No. 2015-491
Mouse Models for Developmental Biology Research (Cga knock-out)
Technology No. 2015-490
Mouse Models for Developmental Biology Research (Msx2-creER)
Technology No. 2015-489
Mouse Models for Developmental Biology Research (pBi-Noggin-eGFP line 53)
Technology No. 2015-488
Mouse Models for Developmental Biology Research (Pax2tm1.1Gdr)
Technology No. 2015-487
Mouse Models for Developmental Biology Research (Pax2tm1Gdr)
Technology No. 2015-486
Mouse Models for Developmental Biology Research (Kcp knock-out)
Technology No. 2015-485
Mouse Models for Developmental Biology Research (Chd7flox)
Technology No. 2015-484
Mouse Models for Developmental Biology Research (Chd7Gt)
Technology No. 2015-483
Mouse Models for Developmental Biology Research (Pitx2 targeted)
Technology No. 2015-482
Mouse Models for Developmental Biology Research (Sec24d gene trapped)
Technology No. 2015-481
Mouse Models for Developmental Biology Research (Tie2-B4galnt2 transgenic)
Technology No. 2015-480
Mouse Models for Developmental Biology Research ((Alb-F5)3 transgenic)
Technology No. 2015-479
Mouse Models for Developmental Biology Research ((Alb-F5)2 transgenic)
Technology No. 2015-478
Mouse Models for Developmental Biology Research (Alb-Ggcx transgenic)
Technology No. 2015-477
Mouse Models for Developmental Biology Research (Cxcl4-F5 transgenic)
Technology No. 2015-476
Mouse Models for Developmental Biology Research (Irs1 knock-out)
Technology No. 2015-475
Mouse Models for Developmental Biology Research (Ggcx knock-out)
Technology No. 2015-474
Mouse Models for Developmental Biology Research (F5 knock-out)
Technology No. 2015-473
Generation of Conditional Rictor Flox/Flox Mice
Technology No. 7541
FloxedTERT Mouse
Technology No. 7354
FIZZ1 Knockout Mouse
Technology No. 7353
Alpha-Smooth Muscle Actin Promoter Constructs
Technology No. 7136
Generation and Characterization of Ovgp1-iCreERT2 Mice
Technology No. 7101
Mouse Model 2 of SCN8A Epilepsy
Technology No. 7008
Generation of Mouse Line to Lineage Trace Gastrin-Expressing Cells
Technology No. 6965
Using Mixed Lineage Leukemia Inhibitors to Treat Neuroendocrine Tumors
Technology No. 6964
Plasmid for Efficient CRISPR/CAS Modulation of Embryonic Stem Cells
Technology No. 6959
Baculovirus LIC Vectors
Technology No. 6890
Antibody to the Adapter Protein SH2B1Beta (Also Known as SH2-Bbeta or PSMbeta)
Technology No. 6823
Humanized PEPT1 Knockin Mice
Technology No. 6798
Luciferase Complementation Reporters for CXCR4 Signaling
Technology No. 6628
p75 Conditional Knockout Mouse
Technology No. 6433
Kallikrein 4 (Klk4) Knockout LacZ Knockin Mouse Model
Technology No. 6388
Mouse Model of SCN8A Epilepsy
Technology No. 6381
Fam83h Conditional Knockout Mouse Model
Technology No. 6293
Fam83h Knockout LacZ Knockin Mouse Model
Technology No. 6292
Wdr72 Knockout LacZ Knockin Mouse Model
Technology No. 6291
Floxed Tor1a Mice
Technology No. 6230
A Global Genetic Model of DYT1 Dystonia
Technology No. 6220
Ameloblastin Knockout LacZ Knockin Mouse Model
Technology No. 6159
Mouse Line to Allow Intestinal Epithelium-Specific Gene Modulation
Technology No. 6098
Generation of Transgenic Mice with Colon-Specific Mosaic Cre CDX2P-G22Cre Mice)
Technology No. 6051
Tumorigenic Human Salivary Mucoepidermoid Carcinoma Cell Lines
Technology No. 5877
Mouse Model of Reversible Central Melanocortin Deficiency and Obesity
Technology No. 5635
CDX2P-CreERT2 Mouse Model
Technology No. 5276
Bacteria Expression Vectors for the Core Components of the MLL Complex
Technology No. 4831
Expression Clone of Mocr-UTX
Technology No. 4634
CARM1 Expression Vector
Technology No. 4556
EZH2 Mammalian Expression Vector
Technology No. 4553
JMJD3 Mammalian Expression Vector
Technology No. 4436
Bacterial Expression Vectors Endocing Chromation Modifying Enzymes
Technology No. 4314
Q54 Mouse Model of Epilepsy Caused by Dominant Mutation of Sodium Channel Scn2a
Technology No. 4077
Conditional Disruption of the ZNF148 (aka ZBP-89) Locus in Mice
Technology No. 4060
Transgenic Rat Podocyte Depletion Model
Technology No. 4017
b6.SJL-Tg(Vil-cre)997Gum/J Transgenic Mice
Technology No. 3832
New Mouse Colon Cancer Progression Model
Technology No. 3132
Galphai2 RGS-insensitive Mouse
Technology No. 2991
ZBP-89 Antibody
Technology No. 2835
ADAMTS13 Exons 1-6 Deficient Mice
Technology No. 2683
A Human Promoter that Directs Podocyte Specific Transgene Expression
Technology No. 2361
Nrl - Knockout Mouse
Technology No. 2114
Pluripotent Mouse Embryonic Stem Cell Line: Pat 5
Technology No. 1862
1B6 Hybridoma Secreting a Murine Monoclonal Antibody Specific for Rat CD11b
Technology No. 1613
a(1,3) Galactosyltransferase Knockout Mouse
Technology No. 1162
Mouse Anti-Alpha6 Integrin Subunit Monoclonal Antibody BQ16
Technology No. 785
Monoclonal Antibody DD23 for Detection of Bladder or Breast Cancer
Technology No. 784
Plasmid Which Expresses Protein Tyrosine Phosphatase
Technology No. 751
Digital molecular fingerprinting of detachable Organ-on-a-chip systems
Technology No. 2023-184
Digital Protein Microarray
Technology No. 2023-128
Syngeneic Model for Tobacco-Associated Squamous Cell Carcinomas
Technology No. 2021-306
LoVo Cell Lines
Technology No. 2022-239
Recombinant monoclonal antibodies against CTNNB1 and FAF1
Technology No. 2023-199
Induction of human alveolar cells via modulation of TGFb and BMP signaling
Technology No. 2023-005
Acoustically-Responsive Bioinks for Extrusion-Based 3D-Bioprinting
Technology No. 2022-091
A novel method to generate stratified esophageal epithelium in 2D
Technology No. 2023-006
EML2 as a Tracker of Shortening Microtubules
Technology No. 2022-123
CDN-Based Compounds and Conjugates for Cancer-Targeted Imaging, Diagnosis and Therapy
Technology No. 2021-270
Magnetically Aligned Synthetic ECM Fibers within a Hydrogel
Technology No. 2021-407
UM-HACC-2A Cells
Technology No. 2021-293
A Transgenic Rabbit Model of Dravet Syndrome
Technology No. 2022-210
UPEC CFT073 Ordered Transposon Mutant Library
Technology No. 2021-030
Antiserums to Xenopus Urocortin 3 (UCN3)
Technology No. 2021-059
Antiserums to Xenopus Urocortin 1 (UCN1)
Technology No. 2021-058
Antiserum to Xenopus Thyroid Stimulating Hormone Beta (TSHb) C-terminus (#4551, #4552)
Technology No. 2021-057
Antiserum to Mouse Thyroid Hormone Receptor Beta (TRb)
Technology No. 2021-056
Antiserums to Xenopus Ten-Eleven Translocation (TET3)
Technology No. 2021-055
Antiserums to Xenopus Mineralocorticoid Receptor (xMR)
Technology No. 2021-054
Antiserum to Xenopus Methyl-CpG Binding Protein 3 (MBD3)
Technology No. 2021-053
Polyclonal Rabbit Antiserum to Xenopus Leptin
Technology No. 2021-052
Antiserum to Xenopus Kruppel-like Factor 9 (KLF9)
Technology No. 2021-050
Antiserums to Xenopus Glucocorticoid Receptor (xGR)
Technology No. 2021-049
Polyclonal Antibodies Recognizing Varies Species of Fluorescent Proteins
Technology No. 7462
AR113Q Knock-In Mice
Technology No. 2019-197
Antiserum to Xenopus Corticotropin-Releasing Factor Binding Protein (CRFBP)
Technology No. 2021-048
Antiserums to Xenopus corticotropin Releasing Factor (CRF)
Technology No. 2021-047
Engineered Mouse Hippocampus-Derived (HT22) Neuronal Cell Lines
Technology No. 2021-029
Engineered Xenopus Laevis Tissue Culture Fibroblast Cell Line
Technology No. 2021-028
Engineered Mouse Neuroblastoma (Neuro2A) Cell Lines; CRISPR/Cas9 Mutation of Dnmt3a
Technology No. 2021-025
UMCHOR-1, Chordoma Cell Line
Technology No. 6355
Xenopus Laevis Tissue Culture Cells; XLT-15, A6, XL-58, XL-177, XTC-2
Technology No. 2021-027
Type I-C CRISPR System from Novel Bacteria as a Tool for Genome Editing in Mammalian Cells
Technology No. 2020-321
sTDP43 Antibody
Technology No. 2020-322
Microfluidic Device for Precise Paired Fusion of Multiple Lipid Droplets
Technology No. 7595
Helical Epitope and Single Chain Fab Fragments to Aid Structural Studies of Membrane Proteins
Technology No. 2020-282
Single Rosette Brain Organoids
Technology No. 2020-255
RPE Cells Overexpressing HA-FLAG-CXCR4 and HA-FLAG-CXCR4-MYC
Technology No. 2020-251
GRASP55 and GRASP65 HeLa and HEK293 Knockout Cell Lines
Technology No. 2018-462
Immortalized Fibroblastic Reticular Cells
Technology No. 2020-201
Polyphosphate and Polyphosphate Derivatives - updated
Technology No. 2020-175
Substituted Oxadiazole and Oxadiazolone as Anti-Cancer Agents
Technology No. 7653
ACL TEAR-ER-IZER
Technology No. 2020-101
Brainbow Antibodies: Polyclonal Antibodies Recognizing Varies Species of Fluorescent Proteins
Technology No. 2020-100
Targeted Infection Prevention Study Toolkit & Implementation Guide
Technology No. 6949
Virtual Maize Navigation Training
Technology No. 7170
